The protective effect of doxofylline against lipopolysaccharides (LPS)-induced activation of NLRP3 inflammasome is mediated by SIRT1 in human pulmonary bronchial epithelial cells-Reference-Cited by-同舟云学术

The protective effect of doxofylline against lipopolysaccharides (LPS)-induced activation of NLRP3 inflammasome is mediated by SIRT1 in human pulmonary bronchial epithelial cells

Published:2020-01-01 Issue:1 Volume:48 Page:687-694
ISSN:2169-1401
Container-title:Artificial Cells, Nanomedicine, and Biotechnology
language:en
Short-container-title:Artificial Cells, Nanomedicine, and Biotechnology

Author:

Jiao Peng¹,Li Weiming²,Shen Lin¹,Li Yan³,Yu Lili³,Liu Zhaohui³

Affiliation:

1. Department of Emergency, Shangqiu First people’s Hospital, Shangqiu, Henan, China

2. The Third Affiliated Hospital, Henan University of Traditional Chinese Medicine, Zhengzhou, Henan, China

3. Department of Anesthesiology, Cangzhou Central Hospital, Cangzhou, Hebei, China

Publisher

Informa UK Limited

Subject

Pharmaceutical Science,Biomedical Engineering,General Medicine,Medicine (miscellaneous),Biotechnology

Link

https://www.tandfonline.com/doi/pdf/10.1080/21691401.2020.1730391

Reference22 articles.

1. The burden of lung disease [internet]. Sheffield (UK): ers white book; https://www.erswhitebook.org/chapters/the-burden-of-lung-disease/

2. Beyond inflammation: airway epithelial cells are at the interface of innate and adaptive immunity

3. Bronchial epithelial cells: The key effector cells in the pathogenesis of chronic obstructive pulmonary disease?

4. Sensing Gram-Negative Bacterial Lipopolysaccharides: a Human Disease Determinant?

5. Innate immunity and tolerance toward mitochondria

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Doxofylline: Advancing and Empowering Equitable Asthma and COPD Management Beyond Tradition;Advanced Therapeutics;2024-06-26

2. Camellia Sinensis Çaylarındaki Moleküllerin NLRP3 NACHT Domainine İn Siliko Bağlanma Afiniteleri;Gümüşhane Üniversitesi Sağlık Bilimleri Dergisi;2023-09-26

3. Oridonin employs interleukin 1 receptor type 2 to treat noise-induced hearing loss by blocking inner ear inflammation;Biochemical Pharmacology;2023-04

4. Doxofylline ameliorates liver fibrosis by regulating the ferroptosis signaling pathway;Frontiers in Pharmacology;2023-03-17

5. Thioredoxin-interacting protein: A new therapeutic target in bone metabolism disorders?;Frontiers in Immunology;2022-08-17